Auto-generated event page
HUTCHMED Initiates Global Trial of PI3K/PIKK-EGFR ATTC Candidate HMPL-A580 in Patients with Solid Tumors
— Second clinical candidate from HUTCHMED’s next-generation ATTC platform —
Score 41
low confidence
1 source posts
Updated Mar 4, 2026, 8:40 AM UTC